Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks
Open Access
- 1 May 2010
- journal article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 4, 525-530
- https://doi.org/10.2147/OPTH.S10649
Abstract
Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks Alfredo Pece1, Gaetano Russo2, Federico Ricci3, Vincenzo Isola1, Ugo Introini4, Giuseppe Querques51Department of Ophthalmology, Melegnano Hospital, Milan, Italy; 2Fondazione Evangelica Betania, Napoli, Italy; 3University of Tor Vergata, Rome, Italy; 5University, Paris XII, France; 4San Raffaele University Hospital, Milan, ItalyPurpose: To report the visual outcome of photodynamic therapy (PDT) combined with intravitreal triamcinolone acetonide (IVTA) for choroidal neovascularization (CNV) secondary to angioid streaks (AS).Methods: Five eyes of five consecutive patients (mean age 45 ± 10 years) with CNV secondary to AS were treated by combination of PDT and IVTA. TA (4 mg/0.1 mL) was injected 7 days before PDT.Results: All patients completed the 12-month follow-up. CNV was subfoveal in three cases and extrafoveal in two. Median best-corrected visual acuity (BCVA) was 0.3 LogMAR (70 letters) at baseline (range 1.3–0.1), and 0.5 LogMAR (60 letters) at the final examination (range 1.0–0.1). At 12 months, one patient had severe visual deterioration, with a loss of seven lines of VA; Two patients lost up to three lines. One patient had no change in BCVA and the fifth gained nine lines of VA. Two patients received one further combination of PDT and IVTA after the first combination treatment. All eyes showed the CNV closure at the 12-month follow-up visit.Conclusions: Combination of PDT and IVTA may reduce the need for retreatment and could be potentially useful for preserving vision in some patients with CNV due to AS. Keywords: ocular corticosteroidsKeywords
This publication has 24 references indexed in Scilit:
- INTRAVITREAL BEVACIZUMAB FOR THE MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION IN PSEUDOXANTHOMA ELASTICUMRetina, 2007
- Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaksIndian Journal Of Ophthalmology, 2007
- Photodynamic Therapy with Intravitreal Triamcinolone in Predominantly Classic Choroidal Neovascularization: One-Year Results of a Randomized StudyOphthalmology, 2006
- Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaksActa Ophthalmologica Scandinavica, 2006
- Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potentialBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
- Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effectCurrent Medical Research and Opinion, 2005
- Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularizationOphthalmology, 2005
- Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularizationOphthalmology, 2003
- LASER PHOTOCOAGULATION OF CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKSPublished by Wolters Kluwer Health ,1997
- Macular Degeneration in Angioid StreaksOphthalmologica, 1987